Cornercap Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.48M | Sell |
23,591
-324
| -1% | -$30.4K | 1.22% | 9 |
|
|
2025
Q3 | $2.01M | Sell |
23,915
-405
| -2% | -$33.4K | 1% | 17 |
|
|
2025
Q2 | $1.93M | Sell |
24,320
-579
| -2% | -$46K | 1% | 14 |
|
|
2025
Q1 | $2.23M | Sell |
24,899
-284
| -1% | -$26.5K | 1.17% | 10 |
|
|
2024
Q4 | $2.51M | Sell |
25,183
-1,000
| -4% | -$103K | 0.81% | 8 |
|
|
2024
Q3 | $2.97M | Sell |
26,183
-17,508
| -40% | -$2.08M | 0.88% | 4 |
|
|
2024
Q2 | $5.41M | Buy |
43,691
+9,678
| +28% | +$1.25M | 0.88% | 5 |
|
|
2024
Q1 | $4.49M | Sell |
34,013
-446
| -1% | -$55K | 0.69% | 7 |
|
|
2023
Q4 | $3.76M | Buy |
34,459
+428
| +1% | +$44.4K | 0.61% | 11 |
|
|
2023
Q3 | $3.5M | Sell |
34,031
-13,463
| -28% | -$1.45M | 0.64% | 11 |
|
|
2023
Q2 | $5.48M | Sell |
47,494
-2,008
| -4% | -$228K | 0.95% | 3 |
|
|
2023
Q1 | $5.27M | Sell |
49,502
-1,994
| -4% | -$215K | 0.93% | 4 |
|
|
2022
Q4 | $5.71M | Sell |
51,496
-1,773
| -3% | -$181K | 0.99% | 3 |
|
|
2022
Q3 | $4.59M | Sell |
53,269
-546
| -1% | -$48.7K | 0.87% | 3 |
|
|
2022
Q2 | $4.91M | Buy |
53,815
+3,427
| +7% | +$304K | 0.85% | 3 |
|
|
2022
Q1 | $4.13M | Buy |
50,388
+2,854
| +6% | +$225K | 0.46% | 26 |
|
|
2021
Q4 | $3.64M | Buy |
47,534
+7,050
| +17% | +$562K | 0.53% | 25 |
|
|
2021
Q3 | $3.04M | Sell |
40,484
-1,571
| -4% | -$119K | 0.35% | 54 |
|
|
2021
Q2 | $3.27M | Sell |
42,055
-3,431
| -8% | -$255K | 0.36% | 58 |
|
|
2021
Q1 | $3.35M | Sell |
45,486
-6,059
| -12% | -$447K | 0.37% | 62 |
|
|
2020
Q4 | $4.47M | Sell |
51,545
-126
| -0.2% | -$9.64K | 0.64% | 18 |
|
|
2020
Q3 | $4.09M | Sell |
51,671
-2,859
| -5% | -$224K | 0.58% | 27 |
|
|
2020
Q2 | $4.02M | Sell |
54,530
-1,211
| -2% | -$91.2K | 0.65% | 23 |
|
|
2020
Q1 | $4.09M | Sell |
55,741
-2,075
| -4% | -$163K | 0.8% | 13 |
|
|
2019
Q4 | $5.02M | Buy |
57,816
+722
| +1% | +$59.3K | 0.68% | 18 |
|
|
2019
Q3 | $4.59M | Buy |
57,094
+3,781
| +7% | +$303K | 0.65% | 23 |
|
|
2019
Q2 | $4.27M | Buy |
53,313
+6,578
| +14% | +$504K | 0.56% | 40 |
|
|
2019
Q1 | $3.71M | Buy |
46,735
+2,308
| +5% | +$173K | 0.51% | 60 |
|
|
2018
Q4 | $3.24M | Buy |
44,427
+40,199
| +951% | +$2.84M | 0.5% | 62 |
|
|
2018
Q3 | $286K | Buy |
4,228
+98
| +2% | +$6.24K | 0.04% | 381 |
|
|
2018
Q2 | $240K | Buy |
4,130
+212
| +5% | +$12K | 0.03% | 381 |
|
|
2018
Q1 | $203K | Sell |
3,918
-142
| -3% | -$7.67K | 0.03% | 390 |
|
|
2017
Q4 | $218K | Sell |
4,060
-54,550
| -93% | -$3.02M | 0.03% | 387 |
|
|
2017
Q3 | $3.58M | Buy |
58,610
+4,576
| +8% | +$277K | 0.5% | 67 |
|
|
2017
Q2 | $3.31M | Buy |
54,034
+48,458
| +869% | +$2.95M | 0.55% | 67 |
|
|
2017
Q1 | $339K | Sell |
5,576
-58,772
| -91% | -$3.57M | 0.06% | 317 |
|
|
2016
Q4 | $3.62M | Buy |
64,348
+59,256
| +1,164% | +$3.47M | 0.62% | 53 |
|
|
2016
Q3 | $304K | Hold |
5,092
| – | – | 0.06% | 331 |
|
|
2016
Q2 | $280K | Hold |
5,092
| – | – | 0.05% | 330 |
|
|
2016
Q1 | $257K | Sell |
5,092
-273
| -5% | -$13.4K | 0.05% | 332 |
|
|
2015
Q4 | $270K | Sell |
5,365
-71
| -1% | -$3.58K | 0.05% | 325 |
|
|
2015
Q3 | $256K | Sell |
5,436
-58
| -1% | -$3.08K | 0.05% | 323 |
|
|
2015
Q2 | $298K | Buy |
5,494
+11
| +0.2% | +$617 | 0.05% | 320 |
|
|
2015
Q1 | $301K | Hold |
5,483
| – | – | 0.05% | 316 |
|
|
2014
Q4 | $297K | Sell |
5,483
-84
| -2% | -$4.68K | 0.05% | 311 |
|
|
2014
Q3 | $315K | Buy |
+5,567
| New | +$313K | 0.06% | 240 |
|
Other funds holding MRK
Cornercap Investment Counsel's MRK Position: Q4 2025 in Review
Cornercap Investment Counsel reduced its Merck (MRK) stake by 1.4% in Q4 2025, selling an estimated $30.4K and leaving 23,591 shares worth $2.48M. The position accounts for 1.22% of the portfolio, ranked #9.
Cornercap Investment Counsel first reported a position in MRK in Q3 2014 and has held it in 46 quarters since. The position peaked at $5.71M in Q4 2022. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Cornercap Investment Counsel held 23,591 shares of Merck worth $2.48M as of Q4 2025.
- Cornercap Investment Counsel sold 324 Merck shares in Q4 2025, an estimated $30.4K.
- Merck made up 1.22% of Cornercap Investment Counsel's portfolio in Q4 2025, its #9 holding.
- Cornercap Investment Counsel first reported a position in Merck in Q3 2014 and has held it in 46 quarters since.
- Cornercap Investment Counsel's Merck position peaked at $5.71M in Q4 2022.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Cornercap Investment Counsel's 13F filing for Q4 2025, filed 13 Feb 2026.